Study: Orphan Drugs Offer ‘Larger Health Gains’ Over Non-Orphan Drugs

April 30, 2020

A recent study led by Tufts CEVR’s James Chambers suggests orphan drugs “offer larger health gains than non-orphan drugs.”

However, the study found that due to their high costs, orphan drugs tend to be less cost-effective.

To learn about the study, click here.

Share This Story!